Mitochondrial DNA haplogroup K1a1b1a is a subclade of the broader haplogroup K, which itself descends from macro-haplogroup R and U. While relatively rare globally, K1a1b1a has gained significant scientific and public attention due to its high prevalence among Ashkenazi Jewish populations and its strong statistical association with two complex disorders: Parkinson’s disease (PD) and Multiple Sclerosis (MS). This paper reviews the phylogenetic placement, geographic distribution, demographic history, and clinical correlations of K1a1b1a, arguing that this haplogroup serves as a unique model for understanding how ancient population bottlenecks and evolutionary adaptations can influence modern disease risk.
The most notable characteristic of K1a1b1a is its high frequency among populations. Research indicates that approximately 19% to 24% of all Ashkenazi Jews belong to this single maternal line. Key historical and genetic findings include: k1a1b1a
The defining genetic mutations for this lineage include transitions at positions , T12954C , and C16234T . These small changes in the mitochondrial genome allow scientists to track the descendants of a single "founding mother" across generations. A Pillar of Ashkenazi Jewish Ancestry Mitochondrial DNA haplogroup K1a1b1a is a subclade of